Investment Summary |
|
---|---|
Date | 2022-05-18 |
Target | Locaweb |
Sector | Internet Software and Services |
Investor(s) | General Atlantic |
Deal Type | Stake Purchase |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Growth Capital Firm |
---|---|
Founded | 1980 |
PE ASSETS | 73.0B USD |
Size | Mega |
Type | Sector Agnostic |
General Atlantic is a large private equity firm that invests globally in growth-oriented public and private companies. Broad areas of interest include financial services, media and consumer, healthcare, enterprise solutions, communications and electronics, and energy. General Atlantic looks to invest $40 to $400 million in transactions that support growth, expansions, buy-outs, consolidations and build-ups. General Atlantic seeks to make 8 to 12 investments per year with an investment horizon of five to ten years. The Firm's geographic coverage spans North America; Europe; Asia/Pacific; and India. General Atlantic was formed in 1980 and is based in Greenwich, Connecticut.
DEAL STATS | # |
---|---|
Overall | 323 of 344 |
Sector (Internet Software and Services) | 70 of 74 |
Type (Stake Purchase) | 35 of 38 |
Country (Brazil) | 15 of 18 |
Year (2022) | 16 of 22 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-05-10 |
Talos
New York, New York, United States Talos is a provider of institutional digital asset trading technology. Talos platform is trusted by the most sophisticated market participants and their end clients for its performance, reliability, and security. Its growing network of services – trading platform, marketplace, data and analytics, and portfolio and settlement tools, all offered directly or through service providers on a white-label basis – enable clients of all types to transact end-to-end without concern for unnecessary intermediary risk or potential conflicts of interest. Talos was founded in 2018 and is based in New York City. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-05-31 |
Ultima Genomics
Newark, California, United States Ultima Genomics focuses on developing next-generation genome sequencing technology for the high-volume research and clinical markets. Ultima Genomics was founded in 2016 and is based in Newark, California. |
Buy | - |